Fragment 176-191 + CJC-1295 (No DAC) + Ipamorelin Blend
Quick summary
A three-part blend: an HGH fragment studied in fat-metabolism models, plus a GHRH analog and a ghrelin-receptor agonist. Research focus: lipolysis models and GH secretagogue research. SRP's starting dose for this compound is still pending.
Component structures:
Amino acid sequence (one-letter code): YADAIFTQSYRKVLAQLSARKLLQDIMSR
Amino acid sequence (one-letter code): AHFFK
Overview
A three-part blend: an HGH fragment studied in fat-metabolism models, plus a GHRH analog and a ghrelin-receptor agonist.
Looking for research material? Simple Research Peptides lists Fragment 176-191 + CJC-1295 (No DAC) + Ipamorelin Blend 12mg for laboratory research use.
Mechanism
This blend combines its components, each acting through its own pathway. See the linked component pages for how each one works.
Research areas
- lipolysis models
- GH secretagogue research
Storage & reconstitution
Supplied as a freeze-dried (lyophilized) powder in a sealed vial. Unopened vials are generally kept cold and away from light. Labs usually reconstitute it with bacteriostatic or sterile water, letting the liquid run down the vial wall and swirling gently instead of shaking. The solution is then kept refrigerated.
Recommended starting dose (low and slow)
| Starting dose | Pending - to be added by SRP |
|---|---|
| Frequency | Pending - to be added by SRP |
| Reconstitution | Pending - to be added by SRP |
Route and timing
Route: Subcutaneous injection after reconstitution is the route most often described in research protocols.
Timing: Pending - to be added by SRP
Cycle length and repeat
Pending - to be added by SRP
Half-life
Approximate, for Bobby's review: Not well characterized in published research.
Side effects
Pending - to be added by SRP
Suggested bloodwork and monitoring
Draft, for Bobby's review: CBC and comprehensive metabolic panel (kidney and liver function, electrolytes) before starting and again after a few weeks; IGF-1, fasting glucose and HbA1c.
Cautions
Pending - to be added by SRP
Reconstitution calculator
Math aid only. It converts the numbers you enter; it is not dosing advice. For research use only.
Frequently asked questions
What is Fragment 176-191 + CJC-1295 (No DAC) + Ipamorelin Blend studied for?
In research it is studied for lipolysis models and GH secretagogue research. This blend combines its components, each acting through its own pathway.
How is Fragment 176-191 + CJC-1295 (No DAC) + Ipamorelin Blend given in research?
Subcutaneous injection after reconstitution is the route most often described in research protocols. SRP has not yet published a frequency for this compound.
What amount should a researcher start with?
SRP has not yet published a starting dose for Fragment 176-191 + CJC-1295 (No DAC) + Ipamorelin Blend. Contact SRP before starting any research protocol, and do not guess.
Related peptides
Last updated: October 19, 2026